Current concepts in gastric motility in diabetes mellitus

Current Diabetes Reviews

Volumn 2, Issue 1, 2006, Pages 113-130

  De Block, Christophe E M ^a   De Leeuw, Ivo H ^a   Pelckmans, Paul A ^a   Van Gaal, Luc F ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Autonomic neuropathy; Diabetes mellitus; Gastric emptying; Prokinetics

Indexed keywords

ANTIDEPRESSANT AGENT; ATROPINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CISAPRIDE; CLARITHROMYCIN; DOMPERIDONE; DOPAMINE RECEPTOR STIMULATING AGENT; ERYTHROMYCIN; GANGLION BLOCKING AGENT; GLUCOSE; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN LISPRO; KETOCONAZOLE; LEVODOPA; METOCLOPRAMIDE; MORPHINE; NICOTINE; NITRIC OXIDE DONOR; OCTREOTIDE; OPIATE DERIVATIVE; ORAL ANTIDIABETIC AGENT; PHOSPHODIESTERASE INHIBITOR; PROKINETIC AGENT; SILDENAFIL; TRANQUILIZER; UNINDEXED DRUG; VINCRISTINE;

ABDOMINAL CRAMP; AMENORRHEA; ANTIEMETIC ACTIVITY; AUTONOMIC NERVOUS SYSTEM FUNCTION; AUTONOMIC NEUROPATHY; BLOATING; BREATH ANALYSIS; CLINICAL ASSESSMENT; CLINICAL TRIAL; DIABETES MELLITUS; DIARRHEA; DIET THERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ERUPTION; DRUG FATALITY; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; ELECTROSTIMULATION THERAPY; EXTRAPYRAMIDAL SYMPTOM; GASTRIC DYSMOTILITY; GASTROINTESTINAL HORMONE DISORDER; GASTROINTESTINAL MOTILITY; GASTROSTOMY; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLYCEMIC CONTROL; HEART ARRHYTHMIA; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HORMONE ACTION; HORMONE RELEASE; HUMAN; HYPERGLYCEMIA; HYPERPROLACTINEMIA; HYPOGLYCEMIA; HYPOTHYROIDISM; INSULIN DEPENDENT DIABETES MELLITUS; JEJUNOSTOMY; LACTATION DISORDER; MORBIDITY; MOTOR ACTIVITY; NAUSEA; NEUROENDOCRINE DISEASE; NEUROTOXICITY; NON INVASIVE MEASUREMENT; NONHUMAN; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; QT PROLONGATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; STOMACH ACID SECRETION; STOMACH PARESIS; STOMACH SCINTISCANNING; STOMACH SPASM; SURGICAL DRAINAGE; SYMPTOM; TORSADE DES POINTES;

DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DUODENUM; EATING; GASTRECTOMY; GASTROINTESTINAL MOTILITY; GASTROPARESIS; HUMANS; JEJUNUM; STOMACH;

EID: 33746233328     PISSN: 15733998     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339906775473662     Document Type: Review

References (286)

1. Boas I. Diseases of the Stomach, 9th edn. Leipzig: Georg Thieme, 1925: 200.
2. Rundless RW. Diabetic neuropathy: general review with report of 125 cases. Medicine 1945; 24: 111-160.
3. Kassander P. Asymptomatic gastric retention in diabetics (gastroparesis diabeticorum). Ann Intern Med 1958; 48: 797-812.
4. Nilsson PH. Diabetic gastroparesis: a review. J Diabetes Complications 1996;10:113-122.
5. Koch KL. Diabetic gastropathy. Gastric neuromuscular dysfunction in diabetes mellitus: a review of symptoms, pathophysiology, and treatment. Dig Dis Sci 1999; 44: 1061-1075.
6. Horowitz M, O'Donovan D, Jones KL, Feinle C, Rayner CK, Samsom M. Gastric emptying in diabetes: clinical significance and treatment. Diabet Med 2002; 19: 177-194.
7. Feldman M, Schiller LR. Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med 1983; 98: 378-384.
8. Jebbink HJA, Bravenboer B, Akkermans LMA, vanBerge-Henegouwen GP, Smout AJPM. Relationships between dyspeptic symptoms and gastrointestinal motility in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993; 36:948-954.
9. Lyrenas EB, Olsoon E, Arvidsson U, Orn TJ, Spjutii JH. Prevalence and determinants of solid and liquid gastric emptying in unstable type 1 diabetes. Relationship to postprandial blood glucose concentrations. Diabetes Care 1997; 20: 413-418.
10. Kong MF, Horowitz M, Jones KL, Wishart JM, Harding PE. Natural history of diabetic gastroparesis. Diabetes Care 1999; 22: 503-507.
11. De Block CEM, De Leeuw IH, Pelckmans PA, Callens D, Máday E, Van Gaal LF. Delayed gastric emptying and gastric autoimmunity in type 1 diabetes. Diabetes Care 2002, 25: 912-917.
12. Samsom M, Vermeijden JR, Smout AJ, et al. Prevalence of delayed gastric emptying in diabetic patients and relationship to dyspeptic symptoms. Diabetes Care 2003;26:3116-3122.
13. Horowitz M, Harding PE, Maddox AF, Akkermans LM, Chatterton B, Shearman DJ. Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1989;32:151-159.
14. Annese V, Bassotti G, Caruso N, et al. Gastrointestinal motor dysfunction, symptoms, and neuropathy in noninsulin-dependent (type 2) diabetes mellitus. J Clin Gastroenterol 1999;29:171-177.
15. Reid B, DiLorenzo C, Travis L, Flores AF, Grill BB, Hyman PE. Diabetic gastroparesis due to postprandial antral motility in childhood. Pediatrics 1992; 90: 43-46.
16. Cucchiara S, Franzese A, Salvia G, et al. Gastric emptying delay and gastric electrical derangement in IDDM. Diabetes Care 1998; 21: 438-443.
17. Horowitz M, Maddox AF, Wishart JM, Harding PE, Chatterton BE, Shearman DJC. Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus. Eur J Nucl Med 1991; 18: 229-234.
18. Scott J, Lloyd-Mostyn RH. Acute autonomic dysfunction in diabetic ketoacidosis. Lancet 1976;1:590.
19. Keshavarian A, Iber FL, Vaeth J. Gastric emptying in patients with insulin requiring diabetes mellitus. Am J Gastroenterol 1987; 82: 29-35.
20. Nowak TV, Johnson CP, Kalbfleisch JH, et al. Highly variable gastric emptying in patients with insulin dependent diabetes mellitus. Gut 1995; 37: 23-29.
21. Lipp RW, Schnedl WJ, Hammer HF, Kotanko P, Leb G, Krejs GJ. Evidence of accelerated gastric emptying in longstanding diabetic patients after ingestion of a semi-solid meal. J Nucl Med 1997; 38: 814-818.
22. Folwaczny C, Wawarta R, Otto B, Friedrich S, Landgraf R, Riepl RL. Gastric emptying of solid and liquid meals in healthy controls compared with long-term type 1 diabetes mellitus under optimal glucose control. Exp Clin Endocrinol Diabetes 2003;111:223-229.
23. Jones KL, Russo A, Berry MK, Stevens JE, Wishart JM, Horowitz M. A longitudinal study of gastric emptying and upper gastrointestinal symptoms in patients with diabetes mellitus. Am J Med 2002;113:449-455.
24. 13C] Octanoic acid breath test for non-invasive assessment of gastric emptying in diabetic patients: validation and relationship to gastric symptoms and cardiovascular autonomic function. Diabetologia 1996; 39:823-830.
25. Jones KL, Horowitz M, Wishart JM, Maddox AF, Harding PE, Chatterton BE. Relationships between gastric emptying, intragastric meal distribution and blood glucose concentrations in diabetes mellitus. J Nucl Med 1995; 35: 2220-2228.
26. Wright RA, Clemente R, Wathen R. Diabetic gastroparesis: an abnormality of gastric emptying of solids. Am J Med Sci 1985; 289: 240-242.
27. Saltzman MB, McCallum RW. Diabetes and the stomach. Yale J Biology Medicine 1983; 56: 179-187.
28. Malagelada JR. Diabetic gastroparesis. Semin Gastrointest Dis 1995;6:181-186.
29. Goyal RK, Hirano I. The enteric nervous system. N Engl J Med 1996; 334: 1106-1115.
30. Peeters TL, Vantrappen G, Janssens J. Fasting plasma motilin levels are related to the interdigestive motility complex. Gastroenterology 1980; 78: 286-293.
31. Achem-Karam SR, Funakoshi A, Vinik AJ, Chung O. Plasma motilin concentration and interdigestive migrating motor complex in diabetic gastroparesis: effect of metoclopramide. Gastroenterology 1985; 88: 492-499.
32. Feldman M, Corbett D, Ramsey EJ, Walsh JH, Richardson CT. Abnormal gastric function in longstanding insulin-dependent diabetic patients. Gastroenterology 1979;77:12-17.
33. Liddle RA, Morita ET, Conrad CK, Williams JA. Regulation of gastric emptying in humans by cholecystokinin. J Clin Invest 1986; 77: 992-996.
34. Gutniak M, Orskov C, Holst JJ, Ahren B, Efendic S. Antidiabetogenic effect of glucagon-like peptide-1 [7-36 amide] in normal subjects and patients with diabetes. N Engl J Med 1992; 326: 1316-1322.
35. Kong MF, King P, Macdonald IA, et al. Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM. Diabetologia, 1997; 40: 82-88.
36. Russo A, Fraser R, Adachi K, Horowitz M, Boeckxstaens G. Evidence that nitric oxide mechanisms regulate small intestinal motility in humans. Gut 1999; 44: 72-76.
37. Azpiroz F, Malagelada JR. Gastric tone measured by an electronic barostat in health and postsurgical gastroparesis. Gastroenterology 1987; 92: 934-943.
38. Sun WM, Hebbard GS, Malbert CH, et al. Spatial patterns of fasting and fed antropyloric pressure waves in humans. J Physiol (Lond) 1997; 19: 455-462.
39. Hebbard GS. Physiology and pathophysiology of gastric emptying. Gastroenterol Int 1998; 11: 150-160.
40. Vantrappen G, Janssens J, Hellemans J, Ghoos Y. The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J Clin Invest 1977; 59: 1158-1166.
41. Horowitz M, Dent J, Fraser R, Sun WM, Hebbard G. Role and integration of mechanisms controlling gastric emptying. Dig Dis Sci 1994; 39: S7-13.
42. Indireschkumar K, Brasseur JG, Faas H, et al. Relative contributions of 'pressure pump' and 'peristaltic pump' to gastric emptying. Am J Physiol 2000; 278: G604-616.
43. Andrews JM, Doran S, Hebbard GS, Malbert CH, Horowitz M, Dent J. Nutrient-induced patterning of human duodenal motor function. Am J Physiol 2001; 280: G501-509.
44. Lin HC, Doty JE, Reedy TJ, Meyer JH. Inhibition of gastric emptying by glucose depends on length of intestine exposed to nutrient. Am J Physiol 1989; 256: G404-411.
45. Horowitz M, Edelbroek M, Wishart JM, Straathof JW. Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects. Diabetologia 1993;36:857-862.
46. Horowitz M, Cunningham KM, Wishart J, Jones KL, Read NW. The effect of short-term dietary supplementation with glucose on gastric emptying of glucose and fructose and oral glucose tolerance in normal subjects. Diabetologia, 1996; 39: 481-486.
47. Corvilain B, Abramowicz M, Fery F, et al. Effect of short-term starvation on gastric emptying in humans: relationship to oral glucose tolerance. Am J Physiol 1995;269:G512-517.
48. Fox S, Behar J. Pathogenesis of diabetic gastroparesis: a pharmacologic study. Gastroenterology 1980; 78: 757-763.
49. Camilleri M, Malagelada JR, Brown ML, Becker G, Zinsmeister AR. Relation between antral motility and gastric emptying of solids and liquids in humans. Am J Physiol 1985; 249: G580-G585.
50. Horowitz M, Harding PE, Maddox A, et al. Gastric and oesophagal emptying in insulin-dependent diabetes mellitus. J Gastroenterol Hepatol 1986; 1: 97-113.
51. Urbain JLC, Vekemans MC, Bouillon R, et al. Characterization of gastric antral motility disturbances in diabetes using a scintigraphic technique. J Nucl Med 1993; 34: 576-581.
52. Koch KL, Stern RM, Stewart WR, Vassey MW. Gastric emptying and gastric myoelectrical activity in patients with diabetic gastroparesis: effect of long-term domperidone treatment. Am J Gastroenterol 1989; 84: 1069-1075.
53. Mearin F, Camilleri M, Malagelada JR. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology 1986; 90: 1919-1925.
54. Samsom M, Roelofs JMM, Akkermans LMA, van Berge-Henegouwen GP, Smout AJPM. Proximal gastric motor activity in response to a liquid meal in type 1 diabetes mellitus with autonomic neuropathy. Dig Dis Sci 1998; 43: 491-496.
55. Samsom M, Jebbink HJA, Akkermans LMA, van Berge-Henegouwen GP, Smout AJPM. Abnormalities of antroduodenal motility in type 1 diabetes. Diabetes Care 1996; 19: 21-27.
56. Fraser R, Horowitz M, Maddox A, Dent J. Postprandial antropyloroduodenal motility and gastric emptying in gastroparesis - effects of cisapride. Gut 1994; 35: 172-178.
57. Hausken T, Odegaard S, Matre Y, Berstad A. Antroduodenal motility and movements of luminal contents studied by duplex sonography. Gastroenterology 1992; 102: 1583-1590.
58. Jones KL, Russo A, Stevens JE, Wishart JM, Berry MK, Horowitz M. Predictors of delayed gastric emptying in diabetes. Diabetes Care 2001; 24: 1264-1269.
59. Kawagishi T, Nishizawa Y, Okuno Y, Sekiya F, Morii H. Effect of cisapride on gastric emptying of indigestible solids and plasma motilin concentration in diabetic autonomic neuropathy. Am J Gastroenterol 1993; 88: 933-938.
60. Abell TL, Camilleri M, Hench V, Malagelada JR. Gastric electromechanical function and gastric emptying in diabetic gastroparesis. Eur J Gastroenterol Hepatol 1991; 19: 163-167.
61. Kawagishi T, Nishizawa Y, Emoto M, et al. Gastric mycoelectrical activity in patients with diabetes: role of glucose control and autonomic nerve function. Diabetes Care 1997; 20: 848-454.
62. Jebbink HJA, Bruijs PPM, Bravenboer B, Akkermans LMA, van Berge-Henegouwen, Smout AJPM. Gastric myoelectrical activity in patients with type I diabetes and autonomic neuropathy. Dig Dis Sci 1994; 39: 2376-2383.
63. Rothstein RD, Alavi A, Reynolds JC. Electrogastrography in patients with gastroparesis and effect of long-term cisapride. Dig Dis Sci 1993; 38: 1518-1524.
64. Hasler WL, Soudah HC, Dulai G, Owyang C. Mediation of hyperglycemia-evoked gastric slow-wave dysrhythmias by endogenous prostaglandins. Gastroenterology 1995; 108: 727-736.
65. Undeland KA, Hausken T, Svebak S, Aanderud S, Berstad A. Wide gastric antrum and low vagal tone in patients with diabetes mellitus type I compared to patients with functional dyspepsia and healthy individuals. Dig Dis Sci 1996; 41: 9-16.
66. Samsom M, Jebbink HJA, Akkermans LMA, van Berge-Henegouwen GP, Smout AJPM. Oral erythromycin improves antroduodenal motility and reduces dyspeptic symptoms in type I diabetics with autonomic neuropathy. Diabetes Care 1997; 20: 129-134.
67. Rayner CK, Verhagen MA, Hebbard GS, DiMatteo AC, Doran SM, Horowitz M. Proximal gastric compliance and perception of distension in type 1 diabetes mellitus: effects of hyperglycaemia. Am J Gastroenterol. 2000; 95: 1175-1183.
68. Hebbard GS, Samson M, Sun WM, Dent J, Horowitz M. Hyperglycaemia affects proximal gastric motor and sensory function during small intestinal triglyceride infusion. Am J Physiol 1996; 271: G814-G819.
69. Barnett JL, Owyang C. Serum glucose concentration as a modulator of interdigestive gastric motility. Gastroenterology 1988; 94: 739-744.
70. Fraser R, Horowitz M, Dent J. Hyperglycaemia stimulates pyloric motility in normal subjects. Gut 1991; 32: 475-478.
71. Verhagen MAMT, Rayner CK, Andrews JM, et al. Physiological changes in blood glucose do not affect gastric compliance and perception in normal subjects. Am J Physiol 1999; 276: G761-766.
72. Enck P, Frieling T. Pathophysiology of diabetic gastroparesis. Diabetes 1997; 46 (Suppl 2): S77-S81.
73. Merio R, Festa A, Bergmann H, et al. Slow gastric emptying in type I diabetes: relation to autonomic and peripheral neuropathy, blood glucose, and glycemic control. Diabetes Care 1997; 20: 419-423.
74. Schvarcz; E, Palmér M, Aman J, Horowitz M, Stridsberg M, Berne C. Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus. Gastroenterology 1997; 113: 60-66.
75. Samsom M, Akkermans LM, Jebbink HJ, van Isselt H, vanBerge-Henegouwen GP, Smout AJ. Gastrointestinal motor mechanisms in hyperglycaemia induced delayed gastric emptying in type I diabetes mellitus. Gut 1997; 40: 641-646.
76. Rayner CK, Samsom M, Jones KL, Horowitz M. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care 2001; 24: 371-381.
77. Holdsworth DC, Besser GM. Influence of gastric emptying rates and insulin response on oral glucose tolerance in thyroid disease. Lancet 1968; ii: 700-702.
78. Kahraman H, Kaya N, Demircali A, Bernay I, Tanyeri F. Gastric emptying time in patients with primary hypothyroidism. Eur J Gastroenterol Hepatol 1997; 9: 901-904.
79. Davies WT, Kirkpatrick JR, Owen GM, Shield R. Gastric emptying in atrophic gastritis and carcinoma of the stomach. Scand J Gastroenterol 1971; 6: 297-301.
80. Bortolotti M, Frada G, Vezzadini P, et al. Influence of gastric acid secretion or interdigestive gastric motor acitivity and serum motilin in the elderly. Digestion 1987; 38: 226-233.
81. Perri F, Ghoos YF, Maes BD, et al. Gastric emptying and Helicobacter pylori infection in duodenal ulcer disease. Dig Dis Sci 1996; 41: 462-468.
82. Saslow SB, Thumshirn M, Camilleri M, et al. Influence of H. pylori infection on gastric motor and sensory function in asymptomatic volunteers. Dig Dis Sci 1998; 43: 258-264.
83. Undeland KA, Hausken T, Aanderund S, Berstad A. Lower postprandial gastric volume response in diabetic patients with vagal neuropathy. Neurogastroenterol Motil 1997; 9: 19-24.
84. Koch KL, Stern RM, Vasey MW, Seaton JF, Demers LM, Harrison TS. Neuroendocrine and gastric myoelectrical responses to illusory self-motion in humans. Am J Physiol 1990; 258: E304-E310.
85. Sheiner HJ, Quinlan MF, Thompson IJ. Gastric motility and emptying in normal and post-vagotomy subjects. Gut 1980;21:753-759.
86. Ejskjaer NT, Bradley JL, Buxton-Thomas MS, et al. Novel surgical treatment and gastric pathology in diabetic gastroparesis. Diabet Med 1999; 16: 488-492.
87. Kristensson K, Nordborg C, Olsson Y, Sourander P. Changes in the vagus nerve in diabetes mellitus. Acta Pathol Microbiol Scand 1971; 79: 684-685.
88. Duchen LW, Anjorin A, Watkins PJ, Mackay JD. Pathology of autonomic neuropathy in diabetes mellitus. Ann Intern Med 1980; 92: 301-303.
89. Guy RJ, Dawson JL, Garrett JR, et al. Diabetic gastroparesis from autonomic neuropathy: surgical considerations and changes in vagus nerve morphology. J Neurol Neurosurg Psychiatry 1984; 47: 686-691.
90. Britland ST, Young RJ, Sharma AY, Lee D, Ah-See AK, Clarke BF. Vagus nerve morphology in diabetic gastropathy. Diabet Med 1990; 7: 780-787.
91. Yoshida MM, Shuffler MD, Sumi SM. There are no morphologic abnormalities of the gastric wall or abdominal vagus in patients with diabetic gastroparesis. Gastroenterology 1988; 94: 907-914.
92. Moscoso GJ, Driver M, Guy RJ. A form of necrobiosis and atrophy of smooth muscle in diabetic autonomic neuropathy. Pathol Res Pract 1986; 181: 188-194.
93. Buysschaert M, Moulart M, Urbain JL, et al. Impaired gastric emptying in diabetic patients with cardiac autonomic neuropathy. Diabetes Care 1987; 10: 448-452.
94. Darwiche G, Almer LO, Bjorgell O, Cederholm C, Nilsson P. Delayed gastric emptying rate in type 1 diabetics with cardiac autonomic neuropathy. J Diabetes Complications 2001; 15: 128-134.
95. Jebbink HJ, Samson M, Bruijs PP, et al. Hyperglycaemia induces abnormalities of gastric myoelectric activity in patients with type I diabetes mellitus. Gastroenterology 1994; 6: 1390-1397.
96. 13C-Oktansäureatemtest zur Messung der Magenentleerung einer festen Testmahlzeit - Korrelation mit der Szintigraphie bei Diabetikem und Reproduzierbarkeit bie gesunden Probanden. Z Gastroenterol 1995; 33: 141-145.
97. Clouse RE, Lustman PJ. Gastrointestinal symptoms in diabetic patients: lack of association with neuropathy. Am J Gastroenterol 1989; 84: 868-872.
98. 13C-octanoic acid breath test versus scintigraphy in diabetics. Z Gastroenterol. 2003; 41: 383-390.
99. Andrews JM, Rayner CK, Doran S, Hebbard GS, Horowitz M. Physiological changes in blood glucose affect appetite and pyloric motility during antroduodenal lipid infusion. Am J Physiol 1998; 275: G797-804.
100. Jones KL, Kong W, Berry MK, Rayner CK, Adamson U, Horowitz M. The effect of erythromycin on gastric emptying is modified by physiological changes in the blood glucose concentration. Am J Gastroenterol 1999; 94: 2074-2079.
101. MacGregor IL, Gueller R, Watts HD, Meyer JH. The effect of acute hyperglycemia on gastric emptying in man. Gastroenterology 1976; 70: 190-196.
102. Soler NG. Diabetic gastroparesis without autonomic neuropathy. Diabetes Care 1980; 3: 200-201.
103. Fraser RJ, Horowitz M, Maddox AF, Harding PE, Chatterton BE, Dent J. Hyperglycaemia slows gastric emptying in type I (insulin-dependent) diabetes mellitus. Diabetologia 1990; 33: 675-680.
104. Schvarcz E, Palmér M, Aman J, Lindkvist B, Beckman KW. Hypoglycemia increases the gastric emptying rate in patients with type 1 diabetes mellitus. Diabet Med 1993; 10: 660-663.
105. Schvarcz E, Palmér M, Aman J, Berne C. Hypoglycemia increases the gastric emptying rate in healthy subjects. Diabetes Care 1995; 18: 674-676.
106. de Boer SY, Masclee AA, Lam WF, Lamers CB. Effects of acute hyperglycemia on esophageal motility and lower esophageal sphincter pressure in humans. Gastroenterology 1992; 103: 775-780.
107. Lam WF, Masclee AA, de Boer SY, Lamers CG. Hyperglycemia reduces gastric secretory and plasma pancreatic polypeptide responses to modified sham feeding in humans. Digestion 1993; 54: 48-53.
108. Coleski R, Gonlachanvit S, Owyang C, Hasler WL. Selective reversal of hyperglycemia-evoked gastric myoelectric dysrhythmias by nitrergic stimulation in healthy humans. J Pharm Exp Ther 2005; 312: 103-111.
109. Kong MF, King P, Macdonald I, et al. Euglycaemic hyperinsulinaemia does not affect gastric emptying in type I and type II diabetes mellitus. Diabetologia 1999; 42: 365-372.
110. Peeters TL. Erythromycin and other macrolides as prokinetic agents. Gastroenterology 1993; 105: 1886-1899.
111. Schmid R, Schusdziarra V, Allescher HD, Bofilias I, Buttermann G, Clasen M. Effects of motilin on gastric emptying in patients with diabetic gastroparesis. Diabetes Care 1990; 14: 65-68.
112. Janssens J, Peeters TL, Vantrappen G, et al. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. N Engl J Med 1990; 322: 1028-1031.
113. Funakoshi A, Glowniak J, Owyang C, Vinik AI. Evidence for cholinergic and vagal noncholinergic mechanisms mediating plasma motilin-like immunoreactivity. J Clin Endocrinol Metab 1982; 54: 1129-1134.
114. Hilsted J. Pathophysiology in diabetic autonomic neuropathy: cardiovascular, hormonal and metabolic studies. Diabetes 1982; 31: 730-737.
115. De Block CEM, De Leeuw IH, Bogers JJPM, et al. Autoimmune gastropathy in type 1 diabetic patients with parietal cell antibodies: histological and clinical findings. Diabetes Care 2003, 26: 82-88.
116. Mitsukawa T, Takemura J, Ogho S, et al. Gallbladder function and plasma cholecystokinin levels in diabetes mellitus. Am J Gastroenterol 1990; 85: 981-985.
117. Yang R, Aram R, Chan L. Gastrointestinal tract complications of diabetes mellitus: pathophysiology and management. Arch Intern Med 1984; 144: 1251-1256.
118. Konturek JW, Fischer H, Gromotka PM, Konturek SJ, Domschke W. Endogenous nitric oxide in the regulation of gastric secretory and motor activity in humans. Aliment Pharmacol Ther 1999; 13: 1683-1691.
119. Orihata M, Sarna SK. Inhibition of nitric oxide synthase delays gastric emptying of solid meals. J Pharmacol Exp Ther 1994; 271: 660-670.
120. Watkins CC, Sawa A, Jaffrey S, et al. Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy. J Clin Invest 2000; 106: 373-384.
121. Sun WM, Doran S, Jones K, et al. Effects of nitroglycerin on liquid gastric emptying and antropyloroduodenal motility. Am J Physiol 1998; 275: G1173-1178.
122. Mouradian M, Abourizk N. Diabetes mellitus and thyroid disease. Diabetes Care 1983; 6: 512-520.
123. De Block CEM, De Leeuw IH, Vertommen JJF, et al. Beta-cell, thyroid, gastric, adrenal and coeliac autoimmunity and HLA-DQ types in type 1 diabetes. Clin Exp Immunol 2001, 126: 236-241.
124. Dubois A, Goldman JM. Gastric secretion and emptying in hypothyroidism. Dig Dis Sci 1984; 29: 407-410.
125. Abbasi AA, Douglass RC, Bissel GW, et al. Myxedema ileus. A form of intestinal pseudo-obstruction. JAMA 1975; 234: 181-183.
126. Wells I, Smith B, Hinton M. Acute ileus in myxoedema. Br Med J 1977; 1: 211.
127. Williams LT, Lefkowitz RJ, Watanabe AM, et al. Thyroid hormone regulation of β-adrenergic receptor number. J Biol Chem 1977; 252: 2787-2789.
128. Duret RL, Bastenie PA. Intestinal disorders in hypothyroidism: clinical and manometric study. Am J Digest Dis 1971; 16: 723
129. Middleton WRJ. Thyroid hormones and the gut Gut 1971; 12: 172-177.
130. Jonderko K, Jonderko G, Marcisz C, Golab T. Gastric emptying in hyperthyroidism. Am J Gastroenterol 1997; 92: 835-838.
131. Baker JT, Harvey RF. Bowel habits in thyrotoxicosis and hyperthyroidism. Br Med J 1971; 1: 322.
132. Shafer RB, Prentiss RA, Bond JH. Gastrointestinal transit in thyroid disease. Gastroenterology 1984; 86: 852-855.
133. Miller LJ, Gorman CA, Go VLW. Gut-thyroid interrelationships. Gastroenterology 1978; 78: 901-911.
134. Christensen J, Schedl HP, Clifton JA. The basic electrical rhythm of the duodenum in normal human subjects and in patients with thyroid disease. J Clin Invest 1964; 43: 1659-1667.
135. Wegener M, Wedmann B, Langhoff T, Schaffstein J, Adamek R. Effect of hyperthyroidism on the transit of a caloric solid-liquid meal through the stomach, the small intestine, and the colon in man. J Clin Endocrinol Metab 1992; 75: 745-749.
136. Bortolotti M, Barbara L. Interdigestive gastroduodenal motor activity in subjects with increased gastric acid secretion. Digestion 1988; 41: 156-160.
137. Vantrappen G, Peeters T, Janssens J. The secretory component of the interdigestive motility motor complex in man. Scand J Gastroenterol. 1979; 14: 663-667.
138. Keane FB, DiMagno EP, Malagelada JR. Duodenogastric reflux in humans: its relationship to fasting antroduodenal motility and gastric, pancreatic, and biliary secretion. Gastroenterology 1981; 81: 726-731.
139. Dalenbäck J, Fändriks L, Olbe L, Sjövall H. Mechanisms behind changes in gastric acid and bicarbonate outputs during the human interdigestive motility cycle. Am J Physiol 1996; 270: G113-G122.
140. Woodtli W, Owyang C. Duodenal pH governs interdigestive motility in humans. Am J Physiol 1995; 268: G146-G152.
141. Gielkens HAJ, Niewenhuizen A, Biemond I, Lamers CBHW, Masclee AAM. Interdigestive antroduodenal motility and gastric acid secretion. Aliment Pharmacol Ther 1998; 12: 27-33.
142. Prakrash C, Marshal BJ, Plankey MW. Gastric emptying of solids in patients with Campylobacter pylori gastritis. Am J Gastroenterol 1987; 82: 935.
143. Wegener M, Börsch G, Schaffstein J, Schulz-Flake E, Mai U, Leverkus F. Are dyspepsia symptoms in patients with Campylobacter pylori-associated type B gastritis linked to delayed gastric emptying. Am J Gastroenterol 1988; 83: 737-740.
144. Barnett JL, Behler EM, Appelman HD, et al. Campylobacter pylori is not associated with gastroparesis. Dig Dis Sci 1989; 34: 1677-1680.
145. Pieramico O, Ditschuneit H, Malfertheiner P. Gastrointestinal motility in patients with nonulcer dyspepsia: a role for Helicobacter pylori infection? Am J Gastroenterol 1993; 88: 364-368.
146. Minocha A, Mokshagundam S, Gallo SH, Rahal PS. Alterations in upper gastrointestinal motility in Helicobacter pylori-positive nonulcer dyspepsia. Am J Gastroenterol 1994; 89: 1797-1800.
147. Jones KL, Wishart JM, Berry M, et al. Helicobacter pylori infection is not associated with delayed gastric emptying of upper gastrointestinal symptoms in diabetes mellitus. Dig Dis Sci 2002; 47: 704-709.
148. Mearin F, de Ribot X, Balboa A, et al. Does Helicobacter pylori infection increase gastric sensitivity in functional dyspepsia? Gut 1995; 37: 47-51.
149. de Luis DA, Cordero JM, Caballero C, et al. Effect of treatment of Helicobacter pylori infection on gastric emptying and its influence on the glycaemic control in type 1 diabetes mellitus. Diabetes Res Clin Pract 2001; 52: 1-9.
150. Folwaczny C, Hundegger K, Volger C, et al. Measurement of transit disorders in different gastrointestinal segments of patients with diabetes mellitus in relation to duration and severity of the disease by use of the metal detector test. Z Gastroenterol 1995; 35: 517-526.
151. Horowitz M, Maddern GJ, Chatterton BE, Collins PJ, Harding PE, Shearman DJC. Changes in gastric emptying rates with age. Clin Sci 1984; 67: 213-218.
152. Datz FL, Christian PE, Moore J. Gender-related differences in gastric emptying. J Nucl Med 1987; 28: 1204-1207.
153. Hutson WR, Roehrkasse RL, Wald A. Influence of gender and menopause on gastric emptying and motility. Gastroenterology 1989; 96: 11-17.
154. Moore JG, Tweedy C, Christian PE, Datz FL. Effect of age on gastric emptying of liquid-solid meals in man. Dig Dis Sci 1983; 28: 340-344.
155. Horowitz M, Collins PJ, Cook DJ, Harding PE, Shearman DJ. Abnormalities of gastric emptying in obese patients. Int J Obes 1983; 7: 415-421.
156. Tosetti C, Corinaldesi R, Stanghellini V, et al. Gastric emptying of solids in morbid obesity. Int J Obes 1996; 20: 200-205.
157. Teff KL, Alavi A, Chen J, Pourdehnad M, Townsend RR. Muscarinic blockade inhibits gastric emptying of mixed nutrient meal: effect of weight and gender. Am J Physiol 1999; 276: R707-R714.
158. Bytzer PM, Talley NJ, Hammer J, Young LJ, Jones MP, Horowitz M. Diabetes mellitus is associated with an increased prevalence of gastrointestinal symptoms: a population-based study of 15,000 adults. Arch Int Med 2001; 86: 5836-5837.
159. Enck P, Rathmann W, Spiekermann M, et al. Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects. Z Gastroenterol 1994; 32: 637-641.
160. Spangeus A, El-Salhy M, Suhr O, Eriksson J, Lithner F. Prevalence of gastrointestinal symptoms in young and middle-aged diabetic patients. Scand J Gastroenterol 1994; 34: 1196-2002.
161. Schvarcz E, Palmer M, Ingberg CM, Aman J, Berne C. Increased prevalence of upper gastrointestinal symptoms in long-term type 1 diabetes mellitus. Diabet Med 1996; 13: 478-481.
162. Maleki D, Locke GR III, Camilleri M, et al. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Int Med 2000; 160: 2808-2816.
163. Ricci JA, Siddique R, Stewart WF, Sandler RS, Sloan S, Farup CE. Upper gastrointestinal symptoms in a US national sample of adults with diabetes. Scand J Gastroenterol 2000; 35: 152-159.
164. Brady PG, Richardson R. Gastric bezoar formation secondary to gastroparesis diabeticorum. Arch Intern Med 1977; 137: 1729.
165. Canivet B, Garnier C, Creisso G, Coussement A, Dujardin P, Freychet P. Gastric bezoar in diabetes mellitus: 3 cases. Nouv Presse Med 1981; 35: 2893-2895.
166. McCallum R, Ricci DA, Rakatansky H, et al. A multicenter placebo-controlled clinical trial of oral metoclopramide in diabetic gastroparesis. Diabetes Care 1983; 6: 463-467.
167. Farup CE, Leidy NY, Murray M, Williams GR, Helbers L, Quigley EMM. Effect of domperidone on the health-related quality of life of patients with symptoms of diabetic gastroparesis. Diabetes Care 1998; 21: 1699-1706.
168. Talley NJ, Bytzer P, Hammer J, Young L, Jones M, Horowitz M. Psychologic distress is linked to gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol 2001; 96: 1033-1038.
169. Lustman PJ, Frank BL, McGill JB. Relationship of personality characteristics to glucose regulation in adults with diabetes. Psychosom Med 1991; 19: 305-312.
170. Iber FL, Parveen S, Vandrunen M, et al. Relation of symptoms to impaired stomach, small bowel, and colon motility in long-standing diabetes. Dig Dis Sci 1993; 38: 45-50.
171. Horowitz M, Harding PE, Chatterton BE, Collins PJ, Shearman DJC. Acute and chronic effects of domperidone on gastric emptying in diabetic autonomic neuropathy. Dig Dis Sci 1985; 30: 1-9.
172. Schade RR, Dagas MC, Lhotsky DM, Gavaler JS, Van Thiel DH. Effect of metoclopramide on gastric liquid emptying in patients with diabetic gastroparesis. Dig Dis Sci 1985; 30: 10-15.
173. Rathmann W, Enck P, Frieling T, Gries FA. Visceral afferent neuropathy in diabetic gastroparesis. Diabetes Care 1991; 14: 1086-1089.
174. Mayer EA, Gebhart GF. Basic and clinical aspects of visceral hyperulgesia. Gastroenterology 1994; 107: 271-293.
175. Lingenfelser T, Sun WM, Hebbard GS, Dent J, Horowitz M. Effects of duodenal distension on antropyloroduodenal pressures and perception are modified by hyperglycemia. Am J Physiol 1999; 276: G711-718.
176. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Review. Diabetes Care 2003; 26: 1553-1579.
177. Xia HH, Talley NJ, Kamm EPY, Young LJ, Hammer J, Horowitz M. Helicobacter pylori infection is not increased or linked to upper gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol 2001; 96: 1039-1042.
178. Bastyr EJ, Stuart CA, Brodows RG, et al. Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbAlc. Diabetes Care 2000; 23: 1236-1241.
179. Ishii M, Nakamura T, Kasai F, Onuma T, Baba T, Takebe K. Altered postprandial insulin requirement in IDDM patients with gastroparesis. Diabetes Care 1994; 17: 901-903.
180. Hebbard GS, Sun WM, Bochner F, Horowitz M. Pharmacokinetic considerations in gastrointestinal motor disorders. Clin Pharmacokinet 1995; 28: 41-66.
181. Parkman HP, Schwartz SS. Esophagitis and gastroduodenal disorders associated with diabetic gastroparesis. Arch Intern Med 1987; 147: 1477-1480.
182. Ewing DJ, Clarke BF. Diagnosis and management of diabetic autonomic neuropathy. Br Med J 1982; 285: 916-918.
183. Ziegler D, Laux G, Dannehl K, Spüler M, Mühlen H, Mayer P, Gries FA. Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses. Diabet Med 1992; 9: 166-175.
184. Lartigue S, Bizais Y, Bruley des Varannes S, Murat A, Pouliqueun B, Glamiche JP. Inter- and intrasubject variability of solid and liquid gastric emptying parameters: a scintigraphic study in healthy subjects and diabetic patients. Dig Dis Sci 1994; 39: 109-115.
185. Collins PJ, Horowitz M, Cook DJ, Harding PE, Shearman DJC. Gastric emptying in normal subjects - a reproducible technique using a single scintillation camera and computer system. Gut 1983; 24: 1117-1125.
186. Camilleri M, Hasler WL, Parkman HP, Quigley EMM, Soffer E. Measurement of gastrointestinal motility in the GI laboratory. Gastroenterology 1998; 115: 747-762.
187. Horowitz M, Dent J. Disordered gastric emptying: mechanical basis, assessment and treatment. Bailliere's Clin Gastroenterol 1991; 5: 371-407.
188. Ghoos YF, Maes BD, Geypens BJ, et al. Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology 1993; 104: 1640-1647.
189. Maes BD, Ghoos YF, Geypens BJ, et al. Combined carbon-13-glycine/ carbon-14-octanoic acid breath test to monitor gastric emptying rates of liquids and solids. J Nucl Med 1994; 35: 824-831.
190. 13C-Octanoic acid breath test for gastric emptying of solids. [Letter] Gastroenterology 1998; 114: 856-857.
191. 13C-Octanoic acid breath test: valueless test for gastric emptying? [Letter] Gastroenterology 1998; 114: 857-858.
192. 13C] Octanoic acid breath test for gastric emptying of solids: accuracy, reproducibility, and comparison with scintigraphy. Gastroenterology 1997; 112: 1155-1162.
193. 13C]octanoic acid breath test. Am J Gastroenterol 2000; 95: 2751-2761.
194. Koch KL, Stern RM. Electrogastrography. In An Illustrated Guide to Gastrointestinal Motility, 2nd Ed. D Kumar, D Wingate (Eds). London, Churchill Livingstone, 1993, pp. 290-307.
195. Parkman HP, Harris AD, Krevsky B, Urbain JLC, Maurer AH, Fisher RS. Gastroduodenal motility on dysmotility: an update on techniques available for evaluation. Am J Gastroenterol 1995; 90: 869-892.
196. Berstad A, Hausken T, Gilja OH, Hveem K, Nesje LB, Odegaard S. Ultrasonography of the human stomach. Scand J Gastroenterol 1996; 31 (Suppl 220): 75-82.
197. Gentilcore D, O'Donovan D, Jones KL, Horowitz M. Nutrition therapy for diabetic gastroparesis. Curr Diab Rep 2003; 3: 418-426.
198. Torsdottir I, Alpsten M, Andersson D, Brummer RJ, Andersson H. Effect of different starchy foods in composite meals on gastric emptying rate and glucose metabolism. I. Comparisons between potatoes, rice and white beans. Hum Nutr Clin Nutr 1984; 38: 329-338.
199. Lipp RW, Schnedl WJ, Hammer HF, Kotanko P, Leb G. Krejs GJ. Effects of postprandial walking on delayed gastric emptying and intragastric meal distribution in longstanding diabetes. Am J Gastroenterol 2000; 95: 419-424.
200. Tack J, Peeters T. What comes after macrolides and other motilin stimulants? Gut 2001; 49: 317-318.
201. Tack J, Broeckaert D, Coulie B, Janssens J. The influence of cisapride on gastric tone and perception of gastric distension. Aliment Pharmacol. Ther 1998; 12: 761-766.
202. Tack J, Coulie B, Wilmer A, et al. Influence of sumitriptan on gastric fundus tone and on the perception of gastric distension in man. Gut 2000; 46: 468-473.
203. Tack J, Caenepeel P, Fischler B. et al. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 2001; 121: 526-535.
204. Verhagen MA, van Schelven LJ, Samsom M, Smout AJ. Pitfalls in the analysis of electrogastrographic recordings. Gastroenterology 1999; 117: 453-460.
205. Pfaffenbach B, Wegener M, Adamek RJ, et al. Antral myoelectric activity, gastric emptying, and dyspeptic symptoms in diabetics. Scand J Gastroenterol 1995; 30: 1166-1171.
206. Verne GN, Sninsky CA. Diabetes and the gastrointestinal tract. Gastroenterol Clin North Am 1998; 27: 861-874.
207. Talley NJ. Diabetic gastropathy and prokinetics. Am J Gastroenterol 2003; 98: 264-271.
208. Abell TL, Camilleri M, Di Magno EP, Hench VS, Zinsmeister AR, Malagelada JR. Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility. Dig Dis Sci 1991; 36: 621-626.
209. Camilleri M, Balm RK, Zinsmeister AR. Symptomatic improvement with one-year cisapride treatment in neuropathic chronic intestinal dysmotility. Aliment Pharmacol Ther 1996; 10: 403-409.
210. Kendall BJ, Kendall ET, Soykan I, McCallum RW. Cisapride in the long-term treatment of chronic gastroparesis: a 2-year open-label study. J Int Med Res 1997; 25: 182-189.
211. Braden B, Enghofer M, Schaub M, et al. Long term cisapride treatment improves diabetic gastroparesis but not glycemic control. Aliment Pharmacol Ther 2002; 16: 1341-1346.
212. Albibi R, McCallum RW. Metoclopramide: pharmacology and clinical application. Ann Intern Med 1983; 98: 86-95.
213. Brownlee M, Kroope SS. Metoclopramide for gastroparesis diabeticorum. N Engl J Med 1974; 291: 1257-1258.
214. Schulze-Delrieu D. Drug therapy: metoclopramide. N Engl J Med 1981; 305: 28-32.
215. McHugh S, Lico S, Diamant NE. Cisapride vs metoclopramide. An acute study in diabetic gastroparesis. Dig Dis Sci 1992; 36: 997-1001.
216. Ganzini L, Casey DE, Hoffman WF, McCall AI. The prevalence of metoclopramide-induced tardive dyskinesia and acute extra-pyramidal movements. Arch Int Med 1993; 153: 1469-1475.
217. Brogden R, Carmine A, Heel R, Speight T, Avery G. Domperidone: a review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic. Drugs 1982; 24:360-400.
218. Soykan I, Sarosiek I, McCallum RW. The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis. Am J Gastroenterol 1997; 92: 976-980.
219. Silvers D, Kipnes M, Broadstone V, et al. Domperidone in the management of diabetic gastroparesis: efficacy, tolerability and quality of life outcomes in a multicenter controlled trial. Clin Ther 1998; 20: 43 8-453.
220. Patterson D. Abell T, Rothstein R, et al. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis. Am J Gastroenterol 1999; 94: 1230-1234.
221. Wiseman LR, Faulds D. Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders. Drugs 1994; 47: 116-152.
222. Horowitz M, Maddox A, Harding PE, Maddern GJ, Chatterton BE, Wishart J, Shearman DJC. Effect of cisapride on gastric and esophageal emptying in insulin-dependent diabetes mellitus. Gastroenterology 1987; 92: 1899-1907.
223. Horowitz M, Jones KL, Harding PE, Wishart JM. Relationship between the effects of cisapride on gastric emptying and plasma glucose concentrations in diabetic gastroparesis. Digestion 2002; 65: 41-46.
224. Johansson UB, Wredling RA, Adamson UC, Lins PE. A randomised study evaluating the effects of cisapride on glucose variability and quality of life parameters in insulin-dependent diabetes mellitus patients. Diabetes Metab 1999; 25: 314-319.
225. Stacher G, Shernthaner G, Francesconi M, et al. Cisapride versus placebo for 8 weeks on glycemic control and gastric emptying in insulin-dependent diabetes: a double-blind cross-over trial. J Clin Endocrinol Metab 1999; 84:2357-2362.
226. Lehmann R, Honegger RA, Feinle C, Fried M, Spinas GA, Schwizer W. Glucose control is not improved by accelerating gastric emptying in patients with type 1 diabetes mellitus and gastroparesis. A pilot study with cisapride as a model drug. Exp Clin Endocrinol Diabetes 2003; 111: 255-261.
227. Camilleri M, Malagelada JR, Abell TL, Brown HL, Hench V, Zinsmeister AR. Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction. Gastroenterology 1989; 96: 704-712.
228. Dutta U, Padhy AK, Ahuja V, Sharma MP. Double-blind controlled trial of cisapride on gastric emptying in diabetics. Trop Gastroenterol 1999; 20: 116-119.
229. Tonini M, De Ponti F, Di Nucci A, Crema F. Review article: cardiac adverse effects of gastrointestinal prokinetics. Aliment Pharmacol Ther 1999; 13: 1585-1591.
230. Coulie B, Tack J, Peeters T, Janssens J. Involvement of two different pathways in the motor effects of erythromycin on the gastric antrum in humans. Gut 1998; 43: 395-400.
231. Richards RD, Davenport K, McCallum RW. The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. Am J Gastroenterol 1993; 88: 203-207.
232. Di Baise JK Quigley EMM. Efficacy of long-term intravenous erythromycin in the management of severe gastroparesis: one center's experience. J Clin Gastroenterol 1999; 28: 131-134.
233. Ehrenpreis ED, Zaitman D, Nellans H. Which form of erythromycin should be used to treat gastroparesis? A pharmacokinetic analysis. Aliment Pharmacol Ther 1998; 12: 373-376.
234. Jones KL, Berry M, Kong MF, Kwiatek MA, Samsom M, Horowitz M. Hyperglycemia attenuates the gastrokinetic effect of erythromycin and affects the perception of postprandial hunger in normal subjects. Diabetes Care 1999; 22: 339-344.
235. Petrakis IE, Chalkiadakis G, Vrachassotakis N, Sciacca V. Vassilakis SJ, Xynos E. Induced hyperglycemia attenuates erythromycin-induced acceleration of hypertonic liquid-phase gastric emptying in type 1 diabetic patients. Dig Dis 1999; 17: 241-247.
236. Petrakis IE, Vrachassotakis N, Sciacca V, Vassilakis SI, Chalkiadakis G. Hyperglycaemia attenuates erythromycin-induced acceleration of solid-phase gastric emptying in idiopathic and diabetic gastroparesis. Scand J Gastroenterol 1999; 34: 396-403.
237. Tanis AA, Baggen MGA, Wiggers RH, Ouwendijk RJ. Side-effects of oral erythromycin for treatment of diabetic gastroparesis. Lancet 1993; 342: 1431.
238. Melga P, Mansi C, Ciuchi E, Giusti R, Sciaba L, Prando R. Chronic administration of levosulpiride and glycemic control in IDDM patients with gastroparesis. Diabetes Care 1997; 20: 55-58.
239. Camilleri M. Tegaserod. Aliment Pharmacol Ther 2001; 15: 277-289.
240. 2-adrenergic agents in humans. Gastroenterology 1999; 116: 573-585.
241. Jones KL, Wishart JM, Berry MK, Abitbol JL, Horowitz M. Effects of fedotozine on gastric emptying and upper gastrointestinal symptoms in diabetic gastroparesis. Aliment Pharmacol Ther 2000; 14: 937-943.
242. Verhagen MA, Samson M, Maes B, et al. Effects of a new motilide, ABT-229, on gastric emptying and postprandial antroduodenal motility in healthy volunteers. Aliment Pharmacol Ther 1997; 11: 1077-1086.
243. Peeters TL. Central and peripheral mechanisms by which ghrelin regulates gut motility. J Physiol Pharmacol 2003; 54 (Suppl 4): 95-103.
244. Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998; 115: 1346-1352.
245. Talley NJ, Verlinden M, Geenen DJ, et al. Efficacy of a motilin receptor agonist (ABT-229) for relief of dyspepsia in type 1 diabetes mellitus: a randomised double-blind placebo controlled trial. Gut 2001; 49: 395-401.
246. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-660.
247. Fujino K, Inui A, Asakawa A, Kihara N, Fujimura M, Fujimiya M. Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats. J Physiol 2003; 550: 227-240.
248. Inui A, Asakawa A, Bowers CY, Mantovani G, Laviano A, Meguid MM, Fujimiya M. Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ. FASEB J 2004; 18: 439-456.
249. Dornonville de la Cour C, Lindström E, Norlén P, Håkanson R. Ghrelin stimulates gastric emptying but is without effect on acid secretion and gastric endocrine cells. Regul Pept 2004; 120: 23-32.
250. Depoortere I, Thijs T, Thielemans L, Robberecht P, Peeters TL. Interaction of the growth hormone-releasing peptides ghrelin and growth hormone-releasing peptide-6 with the motilin receptor in the rabbit gastric antrum. J Pharmacol Exp Ther 2003; 305: 660-667.
251. De Caestecker JS, Ewing DJ, Tothill P, Clarke BF, Heading RC. Evaluation of oral cisapride and metoclopramide in diabetic autonomic neuropathy: an eight-week double-blind cross-over study. Aliment Pharmacol Ther 1989; 3: 69-81.
252. Sturm A, Holtmann G, Goebell H, Gerken G. Prokinetics in patients with gastroparesis: a systematic analysis. Digestion 1999; 60: 422-427.
253. Samsom M, Szarka LA, Camilleri M, Vella A, Zinsmeister AR, Rizza RA. Pramlintide, an amylin analog, selectively delays gastric emptying: potential role of vagal inhibition. Am J Physiol 2000; 278: G946-951.
254. Thompson RG, Pearson L, Schoenfeld SL, Kolterman OG. Pramlintide, a synthetic analog of human amylin, improves the metabolic profile of patients with type 2 diabetes using insulin. The Pramlintide in Type 2 Diabetes Group. Diabetes Care 1998; 21: 987-993.
255. Nyholm B, Orskov L, Hove KJ, et al. The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus. Metabolism 1999; 48: 935-941.
256. Willms B, Werner J, Holst J, Orskov C, Creutzfeldt W, Nauck M. Gastric emptying, glucose response and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1) amide in Type 2 (non-insulin dependent) diabetic patients. J Clin Endocrinol Metab 1996; 81: 327-332.
257. Nauck MA, Holst JJ, Willms B, Schmiegel W. Glucagon-like peptide 1 (GLP-1) as a new therapeutic approach for type 2-diabetes. Exp Clin Endocrinol Diabetes 1997; 105: 187-195.
258. Knudsen LB, Nielsen PF, Huusfeldt PO, et al. Potent derivatives of glucagon-like-peptide-1 with pharmacokinetic properties suitable for once daily administration. J Med Chem 2000; 43: 1664-1669.
259. Deacon CF, Knudsen LB, Madsen K, Wiberg FC, Jacobsen O, Holst JJ. Dipeptidyl peptidase IV resistant analogues of glucagon-like-peptide-1 which have extended metabolic stability and improved biological activity. Diabetologia 1998; 41: 271-278.
260. Buse J, Fineman M, Gottlieb A, Gaines E, Kolterman O. Effects of five-day dosing of synthetic exendin-4 (AC2993) in people with Type 2 diabetes. Diabetes 2000; 49: A100.
261. Selfarth C, Bergmann J, Holst JJ, Ritzel R, Schmiegel W, Nauck MA. Prolonged and enhanced secretion of glucagon-like peptide (7-36 amide) after oral sucrose due to alpha-galactosidase inhibition (acarbose) in type 2 diabetic patients. Diabet Med 1998; 15: 485-491.
262. Ranganath L, Norris F, Morgan L, Wright J, Marks V. Delayed gastric emptying occurs following acarbose administration and is a further mechanism for its antihyperglycaemic effect. Diabet Med 1998; 15: 120-124.
263. Tougas G, Huizinga JD. Gastric pacing as a treatment for intractable gastroparesis - shocking news? Gastroenterology 1998; 114: 598-601.
264. McCallum RW, Chen JDZ, Lin Z, Schirmer BD, Williams RD, Ross RA. Gastric pacing improves emptying and symptoms in patients with gastroparesis. Gastroenterology 1998; 114: 456-461.
265. Gui D, Rossi S, Runfola M, Magalini SC. Review article: botulinum toxin in the therapy of gastrointestinal motility disorders. Aliment Pharmacol Ther 2003; 18: 1-16.
266. Lacy BE, Zayat EN, Crowell MD, Schuster MM. Botulinum toxin for the treatment of gastroparesis: a preliminary report. Am J Gastroenterol 2002; 97: 1548-1552.
267. Ezzeddine D, Jit R, Katz N, Gopalswamy N, Bhutani MS. Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis. Gastrointest Endosc 2002; 55: 920-923.
268. Jones MP, Maganti KM. A systematic review of surgical therapy for gastroparesis. Am J Gastroenterol 2003; 98: 2122-2129.
269. Yamashita S, Yamaguchi H, Sakaguchi M, Satsumae T, Yamamoto S, Shinya F. Longer-term diabetic patients have a more frequent incidence of nosocomial infections after elective gastrectomy. Anesth Analg 2000; 91: 1176-1181.
270. Kim CH, Nelson DK. Venting percutaneous gastrostomy in the treatment of refractory idiopathic gastroparesis. Gastrointest Endosc 1998; 47: 67-70.
271. Michaud L, Guimber D, Carpentier B, et al. Gastrostomy as a decompression technique in children with chronic gastrointestinal obstruction. J Pediatr Gastroenterol Nutr 2001; 32: 82-85.
272. Jacober SJ, Narayan A, Strodel WE, Vinik AI. Jejunostomy feeding in the management of gastroparesis diabeticorum. Diabetes Care 1986; 9: 217-219.
273. Reardon TM, Schnell GA, Schubert TT. Surgical therapy of diabetic gastroparesis. J Clin Gastroenterol 1989; 11: 204-207.
274. Fontana RJ, Barnett JL. Jejunostomy tube placement in refractory diabetic gastroparesis: A retrospective review. Am J Gastroenterol 1996; 91: 2174-2178.
275. Devendra D, Millward BA, Travis SP. Diabetic gastroparesis improved by percutaneous endoscopic jejunostomy. Diabetes Care 2000; 23: 426-427.
276. Hinder RA, Kelly KA. Human gastric pacesetter potential. Site of origin, spread, and response to gastric transection and proximal gastric vagotomy. Am J Surg 1977; 133: 29-33.
277. Miedema BW, Sarr MG, Kelly KA. Pacing the human stomach. Surgery 1992; 111: 143-150.
278. Hocking MP, Vogel SB, Sninsky CA. Human gastric myoelectric activity and gastric emptying following gastric surgery and with pacing. Gastroenterology 1992; 103: 1811-1816.
279. Eagon JC, Kelly KA. Effect of electrical stimulation on gastric electrical activity, motility and emptying. Neurogastroenterol Motil 1995; 7: 39-45.
280. Familoni BO, Abell TL, Voeller G, et al. Electrical stimulation at a frequency higher than basal rate in human stomach. Dig Dis Sci 1997; 42: 885-891.
281. Forster J, Sarosiek I, Delcore R, et al. Gastric pacing is a new surgical treatment for gastroparesis. Am J Surg 2001; 182: 676-681.
282. Wooten RL, Meriweather TW. Diabetic gastric atony - a clinical study. JAMA 1961; 176: 1082-1087.
283. Roon AJ, Mason GR. Surgical management of gastroparesis diabeticorum. Calif Med 1972; 116: 58-61.
284. Bell DS, Ovalle F. Gastroparesis cured by gastrectomy. Diabetes Care 1999; 22: 1000-1001.
285. Watkins PJ, Buxton-Thomas MS, Howard ER. Long-term outcome after gastrectomy for intractable diabetic gastroparesis. Diabet Med 2003; 20: 58-63.
286. Gaber AO, Oxley D, Karas J, et al. Changes in gastric emptying in recipients of combined pancreas-kidney transplants. Dig Dis 1991; 9: 437-443.